Litman 2014.
Methods | Allocation: randomised.
Blindness: double blind. Duration: 28 days. Design: parallel. |
Participants | Diagnosis: people with schizophrenia. N = 151. Age: not reported. Sex: not reported. |
Interventions | 1. Risperidone: 4 mg.
2. Placebo. 3. AZD8529: 40 mg. |
Outcomes | Unable to use: PANSS, CGI. |
Notes | Full text is not available. |